Prochlorperazine Edisylate Injection
Product Images NDC 67457-640

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 67457-640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

FDA Label Image

Carton 10s (Image 02)

This is a medication description for Prochlorperazine Edisylate Injection, USP. It is a solution for deep intramuscular or intravenous use only and should not be used for subcutaneous injections. The usual dosage is not provided, and cautionary instructions are given to protect the injection from light and discard it if discolored. The NDAs and RPNs are available for those looking for more specific information.*

FDA Label Image

Carton 25s (Image 03)

FDA Label Image

Vial (Image 04)

This is a description for an injection with NDC code 67457-640-00. The injection is not for subcutaneous use and should be protected from light. It contains Prochlorperazine and is manufactured in India for Mylan Institutional LLC. The injection is for deep intramuscular or intravenous use only and should be discarded if the contents are markedly discolored.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.